Paper37561596
Tregs with an MHC class II peptide-specific chimeric antigen receptor prevent autoimmune diabetes in mice.
Spanier JA and 14 others. J Clin Invest, 2023. Cited by 84 papers, by iCite.
Cite this record
ConductScience Library. Tregs with an MHC class II peptide-specific chimeric antigen receptor prevent autoimmune diabetes in mice. Papers, record 37561596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37561596
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 1 | Major topic |
| Receptors, Chimeric Antigen | Major topic |
| Mice | |
| Animals | |
| Histocompatibility Antigens Class II | |
| Mice, Inbred NOD | |
| Insulin | |
| T-Lymphocytes, Regulatory |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| T32 AI007313 | NIAID NIH HHS | United States | T32AI007313 | PubMed | NIH RePORTER |
| R21 AI166475 | NIAID NIH HHS | United States | R21AI166475 | PubMed and NIH | NIH RePORTER |
| R01 AI106791 | NIAID NIH HHS | United States | R01AI106791 | PubMed and NIH | NIH RePORTER |
| P01 AI035296 | NIAID NIH HHS | United States | P01AI035296 | PubMed and NIH | NIH RePORTER |
| T35 AI118620 | NIAID NIH HHS | United States | T35AI118620 | PubMed | NIH RePORTER |
| R01 AI156276 | NIAID NIH HHS | United States | R01AI156276 | PubMed and NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Update of | 36865264 |
Source PubMed
References65
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34433860 | Enhanced CD4+ and CD8+ T cell infiltrate within convex hull defined pancreatic islet borders as autoimmune diabetes progresses. | Sci Rep | 2021 | https://conductscience.org/library/papers/34433860 | PubMed |
| 2 | 8671665 | Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. | Int Immunol | 1996 | https://conductscience.org/library/papers/8671665 | PubMed |
| 3 | 36197963 | Pancreatic islet-specific engineered Tregs exhibit robust antigen-specific and bystander immune suppression in type 1 diabetes models. | Sci Transl Med | 2022 | https://conductscience.org/library/papers/36197963 | PubMed |
| 4 | 28027623 | Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection. | Am J Transplant | 2017 | https://conductscience.org/library/papers/28027623 | PubMed |
| 5 | 12415259 | Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. | Nat Med | 2002 | https://conductscience.org/library/papers/12415259 | PubMed |
| 6 | 24686242 | Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells. | Mol Ther | 2014 | https://conductscience.org/library/papers/24686242 | PubMed |
| 7 | 30753169 | Systematic testing and specificity mapping of alloantigen-specific chimeric antigen receptors in regulatory T cells. | JCI Insight | 2019 | https://conductscience.org/library/papers/30753169 | PubMed |
| 8 | 30730852 | Treg gene signatures predict and measure type 1 diabetes trajectory. | JCI Insight | 2019 | https://conductscience.org/library/papers/30730852 | PubMed |
| 9 | 16116193 | Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice. | J Immunol | 2005 | https://conductscience.org/library/papers/16116193 | PubMed |
| 10 | 33053469 | Engineered regulatory T cells expressing myelin-specific chimeric antigen receptors suppress EAE progression. | Cell Immunol | 2020 | https://conductscience.org/library/papers/33053469 | PubMed |
| 11 | 22102287 | A single autoimmune T cell receptor recognizes more than a million different peptides. | J Biol Chem | 2012 | https://conductscience.org/library/papers/22102287 | PubMed |
| 12 | 31176558 | Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes. | J Autoimmun | 2019 | https://conductscience.org/library/papers/31176558 | PubMed |
| 13 | 11137993 | The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. | Nat Genet | 2001 | https://conductscience.org/library/papers/11137993 | PubMed |
| 14 | 29133420 | Resident macrophages of pancreatic islets have a seminal role in the initiation of autoimmune diabetes of NOD mice. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/29133420 | PubMed |
| 15 | 27292946 | Efficient generation of monoclonal antibodies against peptide in the context of MHCII using magnetic enrichment. | Nat Commun | 2016 | https://conductscience.org/library/papers/27292946 | PubMed |
| 16 | 25632005 | A transendocytosis model of CTLA-4 function predicts its suppressive behavior on regulatory T cells. | J Immunol | 2015 | https://conductscience.org/library/papers/25632005 | PubMed |
| 17 | 15855327 | Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes. | Diabetes | 2005 | https://conductscience.org/library/papers/15855327 | PubMed |
| 18 | 22723342 | Administration of CD4+CD25highCD127- regulatory T cells preserves β-cell function in type 1 diabetes in children. | Diabetes Care | 2012 | https://conductscience.org/library/papers/22723342 | PubMed |
| 19 | 15184499 | In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. | J Exp Med | 2004 | https://conductscience.org/library/papers/15184499 | PubMed |
| 20 | 28117148 | Generation of human islet-specific regulatory T cells by TCR gene transfer. | J Autoimmun | 2017 | https://conductscience.org/library/papers/28117148 | PubMed |
Cited by60
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 84 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42799027 | Bioengineered T-cell therapies for precision immunotherapy in renal transplantation, autoimmune relapse, and sensitization. | Clin Kidney J | 2025 | https://conductscience.org/library/papers/42799027 | PubMed |
| 42694788 | FOXP3 Stability-Adaptation Paradox: Reshaping Treg-Based Therapies for Intestinal Diseases. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/42694788 | PubMed |
| 42675035 | Regulatory T cell induction strategies and applications in the treatment of immune and non-immune diseases. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42675035 | PubMed |
| 42661942 | Regulatory T cells in autoimmune diseases: biological mechanisms, clinical translation, and translational challenges. | Front Immunol | 2026 | https://conductscience.org/library/papers/42661942 | PubMed |
| 42598543 | The Role of Chimeric Antigen Receptor Regulatory T Cells in Promoting Immune Tolerance in Solid Organ Transplantation: Mechanisms and Therapeutic Potential. | Saudi Med J | 2026 | https://conductscience.org/library/papers/42598543 | PubMed |
| 42584417 | Receptor-tethered orthogonal IL-2 enhances regulatory T cell therapy. | J Exp Med | 2026 | https://conductscience.org/library/papers/42584417 | PubMed |
| 42317359 | Chimeric antigen receptor technology: an emerging translational immunotherapy in nonneoplastic diseases. | Front Immunol | 2026 | https://conductscience.org/library/papers/42317359 | PubMed |
| 42225638 | Regulatory T cells in cancer and inflammation. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42225638 | PubMed |
| 42158317 | Chimeric Antigen Receptor T-Cell Revolution Remodeling Immunity to Conquer Autoimmune Disease. | Research (Wash D C) | 2026 | https://conductscience.org/library/papers/42158317 | PubMed |
| 42074260 | Targeting the pMHC-TCR Interaction: Molecular Strategies and Therapeutic Potential in Autoimmunity. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42074260 | PubMed |
| 41958676 | Role of Treg cells in diabetes mellitus and association with traditional Chinese medicine: a literature review. | Front Immunol | 2026 | https://conductscience.org/library/papers/41958676 | PubMed |
| 41777899 | Modulating immune response for the prevention and treatment of type 1 diabetes. | Front Immunol | 2026 | https://conductscience.org/library/papers/41777899 | PubMed |
| 41635853 | Oral tolerogenic vaccine combined with gastrin restores immune tolerance and beta-cell function in NOD mice with Type 1 diabetes. | Front Immunol | 2025 | https://conductscience.org/library/papers/41635853 | PubMed |
| 41607801 | The immunobiology and therapeutic potential of regulatory T cells in autoimmune diseases and allergic diseases. | Front Immunol | 2025 | https://conductscience.org/library/papers/41607801 | PubMed |
| 41588112 | Roads and detours for CAR T cell therapy in autoimmune diseases. | Nat Rev Drug Discov | 2026 | https://conductscience.org/library/papers/41588112 | PubMed |
| 41366793 | Convergence of mRNA technology and chimeric antigen receptor therapy: targeted technology optimizing targeted therapy. | J Transl Med | 2025 | https://conductscience.org/library/papers/41366793 | PubMed |
| 41316450 | Challenges and strategies in clinical applications of CAR-T therapy for autoimmune diseases. | J Hematol Oncol | 2025 | https://conductscience.org/library/papers/41316450 | PubMed |
| 41294856 | Improvement of Treg Selectivity and Stability for Diabetes Mellitus Type 1 Treatment: Complex Approach for Perspective Technologies. | Cells | 2025 | https://conductscience.org/library/papers/41294856 | PubMed |
| 41235222 | Opportunities and challenges harnessing antigen-specific CD4+ regulatory T cells in inflammatory bowel disease. | Front Immunol | 2025 | https://conductscience.org/library/papers/41235222 | PubMed |
| 41226824 | Unraveling Type 1 Diabetes: Integrating Microbiome, Metabolomics, and Immunomodulation for Next-Generation Therapies. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41226824 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| FOXP3 | 50943 | PubTator's text mining | https://conductscience.org/library/genes/50943 | NCBI Gene |
| G6PC2 | 57818 | PubTator's text mining | https://conductscience.org/library/genes/57818 | NCBI Gene |
| NR1I3 | 9970 | PubTator's text mining | https://conductscience.org/library/genes/9970 | NCBI Gene |
| SCFV | 652070 | PubTator's text mining | https://conductscience.org/library/genes/652070 | NCBI Gene |
| TRBV20OR9-2 | 6962 | PubTator's text mining | https://conductscience.org/library/genes/6962 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37561596
GET https://conductscience.org/api/papers/v1/37561596/references?page=2